The FDA plans to approve second vaccine after panel endorsement WHO: International vaccine program will get 2 billion doses Snags on U.S. coronavirus relief package may force weekend sessions 1 in 5 prisoners in US has had cornavirus, 1,700 have died
HERE’S WHAT ELSE IS HAPPENING:
TORONTO Prime Minister Justin Trudeau says Canada will be getting 500,000 doses of the Pfizer vaccine in January.
Vaccinations started this week in Canada, a country among the first to approve and distribute the Pfizer vaccine. Trudeau expects 125,000 doses of the vaccine next week and 249,500 this month.
Trudeau says he also expects to get 168,000 doses of the Moderna vaccine before the end of December, pending approval that is expected soon.
Ilustracija/Foto: EPA/ Brian van der Brug / POOL
On December 2, Pfizer and BioNTech submitted documentation for the registration of the coronavirus vaccine in Serbia, after which Medicines and Medical Devices Agency of Serbia began evaluating the documents and thoroughly studying all phases of testing, in order to confirm the efficacy and safety of the vaccine. Immunization with the Pfizer vaccine has already begun on December 8 in Great Britain, and the American Food and Drug Administration (FDA) has given permission for the emergency use of that vaccine. The Pfizer vaccine is also part of the COVAX program.
Read more
Seymour Tribune tribtown.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribtown.com Daily Mail and Mail on Sunday newspapers.
Dec 18, 2020
Registered nurse Sophie Woodbury, left, poses for a photo with state epidemiologist Dr. Angela Dunn, and fellow registered nurses Monte Roberts, Amanda Vicchrilli, William Brunt and Julie Nelson Tuesday at LDS Hospital in Salt Lake city. Woodbury, Roberts, Vicchrilli and Burnt were vaccinated for the coronavirus by Nelson. (Jeffrey D. Allred/The Deseret News via AP)
Here are summaries of the latest Associated Press stories worldwide on the coronavirus pandemic, including: The Food and Drug Administration plans to approve second vaccine after panel endorsement; Snags on U.S. coronavirus relief package may force weekend sessions; U.S. officials debate who should be next in line for the vaccine;